Allos Therapeutics to Present at Rodman & Renshaw Conference
October 20 2004 - 8:00AM
PR Newswire (US)
Allos Therapeutics to Present at Rodman & Renshaw Conference
WESTMINSTER, Colo., Oct. 20 /PRNewswire-FirstCall/ -- Allos
Therapeutics, Inc. (NASDAQ:ALTH) today announced that the Company
will participate in Rodman & Renshaw's Sixth Annual Healthcare
Conference, to be held on October 26-28, 2004 in New York City.
Michael E. Hart, President and Chief Executive Officer of Allos
will give a 20-minute corporate overview on Tuesday, October 26 at
12:55 p.m. EST. The presentation will be webcast live and may be
accessed by visiting the Allos website at http://www.allos.com/. A
replay of the webcast will also be available on the company's
website until Tuesday, November 9, 2004. About Allos Therapeutics,
Inc. Allos Therapeutics, Inc. is a biopharmaceutical company
focused on developing and commercializing innovative drugs for
improving cancer treatments. The company's lead clinical candidate,
EFAPROXYN(TM), is a synthetic small molecule that has the potential
to sensitize hypoxic (oxygen deprived) tumor tissues and enhance
the efficacy of standard radiation therapy. In addition, Allos is
developing PDX (pralatrexate), a novel small molecule cytoxic
injectable antifolate (DHFR inhibitor) that is currently being
investigated in patients with non-small cell lung cancer and non-
Hodgkin's lymphoma. For more information, please visit the
company's web site at: http://www.allos.com/. DATASOURCE: Allos
Therapeutics, Inc. CONTACT: Jennifer Neiman Manager, Corporate
Communications of Allos Therapeutics, +1-720-540-5227, Web site:
http://www.allos.com/
Copyright
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Allos Therapeutics, Inc. (MM) (NASDAQ): 0 recent articles
More Allos Therapeutics (MM) News Articles